stock.name

Aerie Pharmaceuticals Inc

AERI

Market Cap$0
Close$

Compare Aerie Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aerie Pharmaceuticals IncAerie Pharmaceuticals Inc00%22%3.8-1.9
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$16.05

Current Fair Value

5.3% upside

Undervalued by 5.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$140.12 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.77
Beta0.0
Outstanding Shares49,417,407
Avg 30 Day Volume0

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-0.0
Price to Sales3.81
Price to Book Ratio-3.81
Enterprise Value to Revenue0.65
Enterprise Value to EBIT-5.25
Enterprise Value to Net Income-4
Total Debt to Enterprise2.23
Debt to Equity-1.91

Revenue Sources

No data

ESG Score

No data

About Aerie Pharmaceuticals Inc

CEO: Vicente Anido